Prolactin is a peripheral marker of manganese neurotoxicity.
Excessive exposure to Mn induces neurotoxicity, referred to as manganism. Exposure assessment relies on Mn blood and urine analyses, both of which show poor correlation to exposure. Accordingly, there is a critical need for better surrogate biomarkers of Mn exposure. The aim of this study was to examine the relationship between Mn exposure and early indicators of neurotoxicity, with particular emphasis on peripheral biomarkers. Male Wistar rats (180-200g) were injected intraperitoneally with 4 or 8 doses of Mn (10mg/kg). Mn exposure was evaluated by analysis of Mn levels in brain and blood along with biochemical end-points (see below).


RESULTS
Brain Mn levels were significantly increased both after 4 and 8 doses of Mn compared with controls (p<0.001). Blood levels failed to reflect a dose-dependent increase in brain Mn, with only the 8-dose-treated group showing significant differences (p<0.001). Brain glutathione (GSH) levels were significantly decreased in the 8-dose-treated animals (p<0.001). A significant and dose-dependent increase in prolactin levels was found for both treated groups (p<0.001) compared to controls. In addition, a decrease in motor activity was observed in the 8-dose-treated group compared to controls.


CONCLUSIONS
(1) The present study demonstrates that peripheral blood level is a poor indicator of Mn brain accumulation and exposure; (2) Mn reduces GSH brain levels, likely reflecting oxidative stress; (3) Mn increases blood prolactin levels, indicating changes in the integrity of the dopaminergic system. Taken together these results suggest that peripheral prolactin levels may serve as reliable predictive biomarkers of Mn neurotoxicity.
i-Med.UL, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal. apsantos@ff.ul.pt
A P
AP
Marreilha Dos Santos
M
M
Lopes Santos
Maria C
MC
Batoréu
M
M
Aschner
D000818:Animals; D015415:Biomarkers / Q000097:blood; D004195:Disease Models, Animal; D015536:Down-Regulation / Q000187:drug effects / Q000502:physiology; D005978:Glutathione / Q000097:blood / Q000187:drug effects; D008297:Male; D008345:Manganese / Q000097:blood / Q000633:toxicity*; D020149:Manganese Poisoning / Q000097:blood / Q000378:metabolism*; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D011388:Prolactin / Q000097:blood*; D051381:Rats; D017208:Rats, Wistar
D015415:Biomarkers; D008345:Manganese; D011388:Prolactin; D005978:Glutathione
Neurotoxicology. 2008 May;29(3):377-85
18314193
Endocrinology. 1962 Feb;70:272-7
14479575
Neuroradiology. 1997 Aug;39(8):546-50
9272489
J Appl Toxicol. 2000 May-Jun;20(3):179-87
10797470
Neurosci Biobehav Rev. 1991 Fall;15(3):333-40
1956602
Endocr Rev. 2001 Dec;22(6):724-63
11739329
J Neurosci Res. 1999 Apr 15;56(2):113-22
10777372
Pharmacol Toxicol. 1994 Apr-May;74(4-5):294-9
8090702
J Biol Chem. 1988 Nov 25;263(33):17205-8
3053703
Psychoneuroendocrinology. 1981;6(1):3-16
7017786
Neurotoxicology. 1999 Apr-Jun;20(2-3):489-97
10385907
Brain Res. 2010 Apr 22;1326:152-61
20170646
Neurochem Res. 2006 Nov;31(11):1349-57
17053969
Environ Health Perspect. 2006 Aug;114(8):A458; author reply A458
16882508
Biomarkers. 2007 Sep-Oct;12(5):497-509
17701748
J Biol Chem. 1955 May;214(1):489-95
14367406
Exp Neurol. 2002 May;175(1):216-25
12009774
Arch Toxicol. 1997;71(4):223-30
9101038
Trends Neurosci. 2004 Oct;27(10):601-6
15374671
Neurotoxicology. 1992 Spring;13(1):243-7
1508425
Biol Trace Elem Res. 2005 May;104(2):151-63
15894815
Am J Ind Med. 2007 Nov;50(11):801-11
17924418
Reprod Biol. 2006;6 Suppl 1:175-88
16967097
Toxicol Lett. 2000 Mar 15;112-113:35-9
10720710
Free Radic Biol Med. 2001 Sep 15;31(6):763-8
11557314
Environ Res. 2008 Jan;106(1):89-95
17915211
J Environ Monit. 2007 Jul;9(7):650-6
17607384
J Nutr. 1983 Dec;113(12):2601-7
6655516
Biol Res. 2006;39(1):45-57
16629164
Neurotoxicology. 1999 Apr-Jun;20(2-3):287-97
10385891
Sci Total Environ. 2004 Dec 1;334-335:409-16
15504526
Metab Brain Dis. 2002 Dec;17(4):375-87
12602514
Hepatology. 2003 Nov;38(5):1219-26
14578860
Neurotoxicology. 2006 Sep;27(5):765-76
16765446
Neurotoxicology. 2006 Sep;27(5):752-64
16644014
Brain Res. 2008 Oct 21;1236:200-5
18725210
Toxicol Appl Pharmacol. 2003 Oct 1;192(1):1-11
14554098
Neuroreport. 2009 Jan 7;20(1):69-73
19057282
Neurotoxicology. 2007 Mar;28(2):276-83
16824604
Toxicol Sci. 2006 Sep;93(1):114-24
16740617
Toxicol Sci. 2010 May;115(1):194-201
20133376
NMR Biomed. 2004 Dec;17(8):544-53
15617053
Ann Clin Lab Sci. 1996 Jan-Feb;26(1):10-7
8834356
Neurotoxicology. 2006 Sep;27(5):737-44
16545456
Neurotoxicology. 2002 Jul;23(2):169-75
12224758
Toxicol Appl Pharmacol. 2007 Jun 1;221(2):131-47
17466353
Scand J Work Environ Health. 2003 Jun;29(3):230-8
12828393
Endocrinology. 1970 Mar;86(3):503-5
5410438
Am J Ind Med. 2000 Mar;37(3):283-90
10642418
Neurotoxicol Teratol. 2004 Nov-Dec;26(6):811-5
15451044
Pharmacol Ther. 1991;51(2):155-94
1784629
J Psychopharmacol. 2008 Mar;22(2 Suppl):12-9
18477617
Neurotoxicology. 2008 Jul;29(4):569-76
18565586
J Occup Environ Med. 2006 Jun;48(6):644-9
16766929
Proc Natl Acad Sci U S A. 1940 Jul 15;26(7):448-52
16588380
Pharmacol Res. 1997 Oct;36(4):285-92
9425617
Br J Ind Med. 1992 Jan;49(1):25-34
1733453
Exp Neurol. 1996 Apr;138(2):236-45
8620922
Neurotoxicology. 2004 Jun;25(4):543-53
15183009
Environ Toxicol Pharmacol. 2005 May;19(3):797-810
21783557
Neurotoxicology. 1999 Apr-Jun;20(2-3):401-6
10385899
Science. 2003 May 9;300(5621):926-8
12738847
Brain Res. 2008 Apr 8;1203:1-11
18313649
Neurotoxicology. 2006 May;27(3):340-6
16325915
Neurotoxicology. 2007 Sep;28(5):1003-14
17920128
Toxicology. 2005 Jul 1;211(1-2):59-69
15863248